Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding 10/14/2022 OBSERVATIONAL unchanged 1,412.85 0 PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer 10/14/2022 INTERVENTIONAL unchanged 1,412.85 0 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy 10/17/2022 INTERVENTIONAL unchanged 1,409.85 0 Engage & Connect: A Psychotherapy for Postpartum Depression 10/18/2022 INTERVENTIONAL unchanged 1,408.85 0 Pulsed Lavage in Implant-Based Breast Reconstruction 10/19/2022 INTERVENTIONAL unchanged 1,407.85 0 Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP) 10/19/2022 INTERVENTIONAL unchanged 1,407.85 0 Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy 10/19/2022 INTERVENTIONAL unchanged 1,407.85 0 Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension 10/19/2022 OBSERVATIONAL unchanged 1,407.85 0 A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer 10/20/2022 INTERVENTIONAL unchanged 1,406.85 0 Monitoring of Chronic Conditions in Breast Cancer 10/20/2022 OBSERVATIONAL unchanged 1,406.85 0 Efficacy of Mobile Health Application in Promotion of Exclusive Breast Feeding and Young Child Feeding Practices in Pakistan 10/21/2022 INTERVENTIONAL unchanged 1,405.85 0 Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors 10/21/2022 OBSERVATIONAL unchanged 1,405.85 0 Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen 10/24/2022 INTERVENTIONAL unchanged 1,402.85 0 Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) 10/25/2022 INTERVENTIONAL unchanged 1,401.85 0 SNF Platform Study of HR+/ HER2-advanced Breast Cancer 10/26/2022 INTERVENTIONAL unchanged 1,400.85 0 Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors 10/27/2022 INTERVENTIONAL unchanged 1,399.85 0 Perinatal Research on Improving Sleep and Mental Health 10/27/2022 INTERVENTIONAL unchanged 1,399.85 0 REBOA in Life-threatening Postpartum Hemorrhage (PPH) in Uganda 10/28/2022 INTERVENTIONAL unchanged 1,398.85 0 LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema 11/01/2022 INTERVENTIONAL unchanged 1,394.85 0 Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) 11/01/2022 INTERVENTIONAL unchanged 1,394.85 0 ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) 11/01/2022 INTERVENTIONAL unchanged 1,394.85 0 TARGETing Healthy Weight Loss in the Context of Food Insecurity 11/01/2022 OBSERVATIONAL unchanged 1,394.85 0 Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS 11/02/2022 INTERVENTIONAL unchanged 1,393.85 0 A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN) 11/02/2022 INTERVENTIONAL unchanged 1,393.85 0 Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma 11/03/2022 INTERVENTIONAL unchanged 1,392.85 0 Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women 11/03/2022 INTERVENTIONAL unchanged 1,392.85 0 Healthier At-home Meals for Expectant Mothers 11/04/2022 INTERVENTIONAL unchanged 1,391.85 0 Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer 11/04/2022 INTERVENTIONAL unchanged 1,391.85 0 Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers 11/04/2022 INTERVENTIONAL unchanged 1,391.85 0 A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study) 11/07/2022 INTERVENTIONAL unchanged 1,388.85 0 Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) 11/07/2022 INTERVENTIONAL unchanged 1,388.85 0 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer 11/07/2022 INTERVENTIONAL unchanged 1,388.85 0 Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial 11/07/2022 INTERVENTIONAL unchanged 1,388.85 0 1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV 11/08/2022 INTERVENTIONAL unchanged 1,387.85 0 Continuous And Data-drivEN CarE (CADENCE) Pilot 11/08/2022 INTERVENTIONAL unchanged 1,387.85 0 Combination Therapy for Recurrent Ovarian Cancer 11/09/2022 INTERVENTIONAL unchanged 1,386.85 0 Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients 11/10/2022 OBSERVATIONAL unchanged 1,385.85 0 Confounding Factors of Chronic Endometritis in Women With Reproductive Failure 11/14/2022 OBSERVATIONAL unchanged 1,381.85 0 Primary Cervical Cancer Screening by Self-sampling HPV Test 11/14/2022 OBSERVATIONAL unchanged 1,381.85 0 Neurofeedback During Eating for Bulimia Nervosa 11/14/2022 INTERVENTIONAL unchanged 1,381.85 0 Postpartum Intervention for Mothers With Opioid Use Disorders 11/14/2022 INTERVENTIONAL unchanged 1,381.85 0 Long-term Ovarian Fertility in Patients Treated for Lymphoma. 11/15/2022 OBSERVATIONAL unchanged 1,380.85 0 Laparoscopic Burch Colposuspension Versus Modified Burch Colposuspension 11/15/2022 INTERVENTIONAL unchanged 1,380.85 0 Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast Cancer 11/15/2022 INTERVENTIONAL unchanged 1,380.85 0 Treating Chronic Cervicogenic Head and Neck Pain 11/15/2022 INTERVENTIONAL unchanged 1,380.85 0 AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer 11/15/2022 INTERVENTIONAL unchanged 1,380.85 0 Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities? 11/16/2022 INTERVENTIONAL unchanged 1,379.85 0 The Effect of Pelvic Floor Muscle Training for Urinary Incontinence in Nepalese Women 11/16/2022 INTERVENTIONAL unchanged 1,379.85 0 Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women 11/17/2022 INTERVENTIONAL unchanged 1,378.85 0 Young Adult Education on Alcohol & Health 11/17/2022 INTERVENTIONAL unchanged 1,378.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology